Summary
- Current Price
- As of today, VRDN price is $28.68, up +0.95% on
- Current Price All-Time High
- VRDN price is currently -98.72% below its historical high of $2,247.75 set on
- Market Cap
- VRDN current market cap is $3B, up +112.48% over the past 365 days
- PE Ratio
- VRDN PE ratio is unknown
- Revenue
- VRDN current annual revenue is $70.85M, up +23359.93% year-over-year
- Next Earnings
- The next earnings release for VRDN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Viridian Therapeutics, Inc. |
| Ticker | NASDAQ: VRDN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | viridiantherapeutics.com |
| Employees | 143 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $28.68 | |
| Price, 1D Change | +0.95% | |
| $3B | ||
| - | ||
| - | ||
| 0.95 | ||
| $71M | ||
| Revenue, 1Y Change | +23,359.93% | |
| -$3.32 | ||
| EPS, 1Y Change | -8.21% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MGEN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.32 | ||
| EPS Estimate | N/A | -$3.79 |
| EPS Est. Change | N/A | -14.06% |
| $70.85M | ||
| Revenue Estimate | N/A | $78.89M |
| Revenue Est. Change | N/A | +11.35% |
| Current Price | $28.68 | |
| Price Target | - | $42.00 |
| Price Tgt. Change | - | +46.44% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.99 | -$3.07 | +22.96% | |
| -$3.54 | -$3.32 | +5.96% | |
| -$3.79 | N/A | -14.06% | |
| -$2.05 | N/A | +38.38% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $314.57K | $302.00K | -4.00% | |
| $86.48M | $70.85M | -18.07% | |
| $78.89M | N/A | +11.35% | |
| $307.00M | N/A | +333.32% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $28.68 | |
| $23.71 | ||
| SMA 200 vs Price | -17.32% | |
| $30.52 | ||
| SMA 50 vs Price | +6.42% | |
| 0.95 | ||
| $1.62 | ||
| 45.33 | ||
| 49.67% | ||
| 50.58% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $70.85M | ||
| -$3.32 | ||
| $69.69M | ||
| 98.36% | ||
| -$363.40M | ||
| -512.91% | ||
| -$281.93M | ||
| -397.93% | ||
| -$362.24M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.07 | ||
| 12.65 | ||
| 12.65 | ||
| - | ||
| 2 | ||
| 7.03 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 38.64 | ||
| 4.64 | ||
| -5.28 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $590.11M | ||
| $874.65M | ||
| $899.42M | ||
| $894.23M | ||
| $177.25M | ||
| $70.70M | ||
| $50.69M | ||
| $753.00K | ||
| $8.68M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $352.78M | ||
| $433.08M | ||
| $1.16M | ||
| $95.32M | ||
| $460.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$276.87M | ||
| -$37.56M | ||
| $427.22M | ||
| $495.00K | ||
| -$277.36M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| RBC Capital | → | |
| Needham | → | |
| Wells Fargo | → | |
| Truist Securities | → | |
| UBS | ||
| Needham | → | |
| Wedbush | → | |
| William Blair | ||
| Truist Securities |
Analyst sentiment
Institutional ownership
Screeners with VRDN
FAQ
What is the ticker symbol for Viridian Therapeutics, Inc.?
The ticker symbol for Viridian Therapeutics, Inc. is NASDAQ:VRDN
Does Viridian Therapeutics, Inc. pay dividends?
No, Viridian Therapeutics, Inc. does not pay dividends
What sector is Viridian Therapeutics, Inc. in?
Viridian Therapeutics, Inc. is in the Healthcare sector
What industry is Viridian Therapeutics, Inc. in?
Viridian Therapeutics, Inc. is in the Biotechnology industry
What country is Viridian Therapeutics, Inc. based in?
Viridian Therapeutics, Inc. is headquartered in United States
When did Viridian Therapeutics, Inc. go public?
Viridian Therapeutics, Inc. initial public offering (IPO) was on June 18, 2014
Is Viridian Therapeutics, Inc. in the S&P 500?
No, Viridian Therapeutics, Inc. is not included in the S&P 500 index
Is Viridian Therapeutics, Inc. in the NASDAQ 100?
No, Viridian Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Viridian Therapeutics, Inc. in the Dow Jones?
No, Viridian Therapeutics, Inc. is not included in the Dow Jones index
When was Viridian Therapeutics, Inc. last earnings report?
Viridian Therapeutics, Inc.'s most recent earnings report was on February 26, 2026
When does Viridian Therapeutics, Inc. report earnings?
The next expected earnings date for Viridian Therapeutics, Inc. is May 6, 2026
Data Sources & References
- VRDN Official Website www.viridiantherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1590750/000159075026000007/0001590750-26-000007-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590750/000159075026000007/0001590750-26-000007-index.htm
- VRDN Profile on Yahoo Finance finance.yahoo.com/quote/VRDN
- VRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrdn